Antibiotics

Petri dish used for bacterial research
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Bacteria #Sepsis #University of Queensland

Australian sepsis study to power new antibiotic discoveries

University of Queensland (UQ) researchers have led a national study on the four main bacteria that cause sepsis, providing new targets for developing antibiotics. Professor Mark Walker and Professor Mark Schembri from UQ’s Institute for Molecular Bioscience, along with Dr Andre Mu from the University of… Read More

#Editor's Choice #News

Bacteria in Petri dishes
#Antibiotics #Antibodies #Antimicrobial resistance (AMR) #Antimicrobials #Cystic fibrosis #Funding #LifeArc

£3m drug discovery programme for cystic fibrosis

UK-based Cystic fibrosis (CF) Syndicate in Antimicrobial Resistance (AMR) has announced a £3 million ($3.6 million) Collaborative Discovery Programme for drug discovery innovators to accelerate the development of new treatments for people with CF. Funded by UK medical research charity LifeArc, the programme will support approximately… Read More

#News

Antimicrobial resistance
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #The Global Antibiotic Research and Development Partnership #University of Liverpool

GARDP and the University of Liverpool join forces against AMR

The Global Antibiotic Research and Development Partnership (GARDP) and the University of Liverpool have confirmed an agreement to collaborate on new projects to address antimicrobial resistance (AMR) for the benefit of public health. Since 2018, GARDP and the University of Liverpool have been working together to… Read More

#Editor's Choice #News

Dr Yue Wang and Professor Jianhua Guo
#Antibiotic resistance #Antibiotics #Antidepressants #Antimicrobial resistance (AMR) #Psychiatry

Common antidepressants increase antibiotic resistance

Researchers have found a range of commonly prescribed antidepressants can increase bacteria’s resistance to antibiotic medications. A study led by Professor Jianhua Guo from University of Queensland’s Australian Centre for Water and Environmental Biotechnology focused on prescription drugs used to treat depressive disorders, anxiety disorders, and other psychological… Read More

#News

Professor Stefano Pagliara
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #European Research Council #Funding

$2 million awarded to antibiotic resistance researcher

A major boost of £1.76 million ($2.16 million) will fund research designed to stop antibiotics failing, to help mitigate the rising threat of antibiotic resistance.  Professor Stefano Pagliara, at the University of Exeter, has received the award to advance his work on controlling the processes and biological… Read More

#News

Scientists in laboratory
#Antibiotics #Antimicrobial resistance (AMR) #Antimicrobials #Collaboration #Cresset Discovery #Partnership #Screening

Virtual screening partners to find new antimicrobial drugs

Cresset Discovery and the University of Exeter have entered a collaboration to discovery novel antimicrobial drugs.  Cresset Discovery will use virtual screening to identify promising new candidates, building on research led by Dr Stefano Pagliara.  Virtual screening enables chemists to explore new chemical space, discover… Read More

#News

Antibiotics
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Antimicrobials

World Antimicrobial Awareness Week: Antibiotics in the news 

For World Antimicrobial Awareness Week (18-24 November), DDW’s Diana Spencer provides an overview of the latest news in antimicrobial resistance and drug discovery.  1. New class of antibiotics for TB A first-in-class investigational antitubercular agent has shown early bactericidal activity with a low, once-daily oral dose after 14 days of… Read More

#Exclusive Content #News #Trending News

Pseudomonas aeruginosa
#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Antimicrobials #Gut microbiome

How antibiotic resistant gut bacteria cause lung infections

An Oxford University study has provided the first evidence that antibiotic resistant bacteria can travel from the gut to the lung, increasing the risk of deadly infections.  The findings coincide with World Antimicrobial Awareness Week and shed light on how antimicrobial resistance (AMR) arises and persists.  … Read More

#News #Trending News

#Antibiotics #Antimicrobial resistance (AMR) #Cancer #Cancer research #Cell therapy #Covid-19 #Drug discovery #Oncology

Five key news stories available on DDW Highlights podcast

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  This week started with World Diabetes Day on 14 November and concluded… Read More

#News

#Antibiotics #Antimicrobial resistance (AMR) #Cancer #Cancer research #Cell therapy #Covid-19 #Drug discovery #Oncology

This week in drug discovery (14-18 November)

News round-up for 14-18 November by DDW Digital Content Editor Diana Spencer.  This week started with World Diabetes Day on 14 November and concluded with the start of World Antimicrobial Awareness Week, which aims to improve education and understanding of the growing issue of antimicrobial resistance. … Read More

#News

World AMR Awareness Week logo
#ABPI #Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR) #Association of the British Pharmaceutical Industry #UK

New antibiotics the only way to combat AMR, says ABPI 

Developing new antibiotics is essential to winning the fight against resistant infections, the Association of the British Pharmaceutical Industry (ABPI) has said.  The comments come ahead of World Antimicrobial Awareness Week (18-24 November), which aims to improve the awareness and understanding of antimicrobial resistance (AMR).   The… Read More

#News #Trending News

Patient taking antibiotics
#Antibiotics #GSK #Phase II trial #TB #Tuberculosis

New class of antibiotics could help address the TB epidemic 

A first-in-class investigational antitubercular agent has shown early bactericidal activity with a low, once-daily oral dose after 14 days of treatment.  The Phase IIa study evaluated GSK’s GSK3036656 in participants with drug-susceptible pulmonary tuberculosis. The company hopes GSK3036656 could be a component of simpler treatment regimens in… Read More

#News #Trending News

#Antibiotic resistance #Antibiotics #Contraception #Contraceptive pill #Covid-19 #Drug development #Drug discovery #Idiopathic pulmonary fibrosis #Respiratory syncytial virus

This week in drug discovery (17-21 October)

News round-up for 17-21 October by DDW Digital Content Editor Diana Spencer  Amid continued concern about antibiotic resistance, the headline news this week was the discovery of a new antibiotic that could be effective against some of the most treatment-resistant pathogens.   However, there was also… Read More

#News

#Antibiotic resistance #Antibiotics #Antimicrobial resistance (AMR)

Why the UK government’s antibiotics plans are irresponsible   

By DDW Editor Reece Armstrong  The threat of antimicrobial resistance (AMR) has long been a talking point for those invested in healthcare and life sciences. Indeed, for many, it is a looming threat for which inaction could result in very serious consequences for healthcare systems worldwide.   AMR is currently listed… Read More

#Exclusive Content #Opinion

Antibiotics
#Antibiotic resistance #Antibiotics #Bacterial genome #Gram-negative bacteria #Northeastern University #University of Basel

New antibiotic could kill resistant pathogens

An international team of researchers has discovered a new antibiotic by computational analysis and deciphered its mode of action.  The researchers also found that Dynobactin kills Gram-negative bacteria, which include many dangerous and resistant pathogens.  The team were led by researchers from the Northeastern University… Read More

#News #Trending News

#Antibiotics #Antimicrobial resistance (AMR) #Vaccines #WHO

Urgency a must for global fight against AMR, report says  

Urgent access to vaccines that can fight and prevent infections, and curb the risk of antimicrobial resistance (AMR) is needed to save lives, according to a report by the World Health Organisation (WHO).  WHO has released the first-ever report1 looking at the pipeline of vaccines currently in… Read More

#News #Trending News